BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26130468)

  • 1. A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.
    Assi N; Fages A; Vineis P; Chadeau-Hyam M; Stepien M; Duarte-Salles T; Byrnes G; Boumaza H; Knüppel S; Kühn T; Palli D; Bamia C; Boshuizen H; Bonet C; Overvad K; Johansson M; Travis R; Gunter MJ; Lund E; Dossus L; Elena-Herrmann B; Riboli E; Jenab M; Viallon V; Ferrari P
    Mutagenesis; 2015 Nov; 30(6):743-53. PubMed ID: 26130468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.
    Assi N; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen HC; Sundkvist A; Kühn T; Travis RC; Overvad K; Riboli E; Gunter MJ; Scalbert A; Jenab M; Ferrari P; Viallon V
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):531-540. PubMed ID: 29563134
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort.
    Assi N; Gunter MJ; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen H; Sundkvist A; Kühn T; Travis R; Overvad K; Riboli E; Scalbert A; Jenab M; Viallon V; Ferrari P
    Am J Clin Nutr; 2018 Jul; 108(1):117-126. PubMed ID: 29924298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
    Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
    Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.
    Fages A; Duarte-Salles T; Stepien M; Ferrari P; Fedirko V; Pontoizeau C; Trichopoulou A; Aleksandrova K; Tjønneland A; Olsen A; Clavel-Chapelon F; Boutron-Ruault MC; Severi G; Kaaks R; Kuhn T; Floegel A; Boeing H; Lagiou P; Bamia C; Trichopoulos D; Palli D; Pala V; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Agudo A; Molina-Montes E; Huerta JM; Ardanaz E; Dorronsoro M; Sjöberg K; Ohlsson B; Khaw KT; Wareham N; Travis RC; Schmidt JA; Cross A; Gunter M; Riboli E; Scalbert A; Romieu I; Elena-Herrmann B; Jenab M
    BMC Med; 2015 Sep; 13():242. PubMed ID: 26399231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.
    Aleksandrova K; Bamia C; Drogan D; Lagiou P; Trichopoulou A; Jenab M; Fedirko V; Romieu I; Bueno-de-Mesquita HB; Pischon T; Tsilidis K; Overvad K; Tjønneland A; Bouton-Ruault MC; Dossus L; Racine A; Kaaks R; Kühn T; Tsironis C; Papatesta EM; Saitakis G; Palli D; Panico S; Grioni S; Tumino R; Vineis P; Peeters PH; Weiderpass E; Lukic M; Braaten T; Quirós JR; Luján-Barroso L; Sánchez MJ; Chilarque MD; Ardanas E; Dorronsoro M; Nilsson LM; Sund M; Wallström P; Ohlsson B; Bradbury KE; Khaw KT; Wareham N; Stepien M; Duarte-Salles T; Assi N; Murphy N; Gunter MJ; Riboli E; Boeing H; Trichopoulos D
    Am J Clin Nutr; 2015 Dec; 102(6):1498-508. PubMed ID: 26561631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.
    Nahon P; Amathieu R; Triba MN; Bouchemal N; Nault JC; Ziol M; Seror O; Dhonneur G; Trinchet JC; Beaugrand M; Le Moyec L
    Clin Cancer Res; 2012 Dec; 18(24):6714-22. PubMed ID: 23136190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II.
    Jee SH; Kim M; Kim M; Yoo HJ; Kim H; Jung KJ; Hong S; Lee JH
    Cancer Prev Res (Phila); 2018 May; 11(5):303-312. PubMed ID: 29500188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.
    Gao H; Lu Q; Liu X; Cong H; Zhao L; Wang H; Lin D
    Cancer Sci; 2009 Apr; 100(4):782-5. PubMed ID: 19469021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.
    Huang BY; Tsai MR; Hsu JK; Lin CY; Lin CL; Hu JT; Huang YW; Liu CJ; Wu WJ; Wu CF; Sung FY; Chen PJ; Liang HJ; Lin SM; Yu MW
    Mol Carcinog; 2020 Nov; 59(11):1269-1279. PubMed ID: 32914490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
    Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
    World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
    Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
    Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
    Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
    J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.
    Stepien M; Duarte-Salles T; Fedirko V; Floegel A; Barupal DK; Rinaldi S; Achaintre D; Assi N; Tjønneland A; Overvad K; Bastide N; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Bamia C; Lagiou P; Saieva C; Agnoli C; Panico S; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez MJ; Dorronsoro M; Gavrila D; Barricarte A; Ohlsson B; Sjöberg K; Werner M; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Gunter M; Cross A; Vineis P; Romieu I; Scalbert A; Jenab M
    Int J Cancer; 2016 Jan; 138(2):348-60. PubMed ID: 26238458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Fedirko V; Trichopolou A; Bamia C; Duarte-Salles T; Trepo E; Aleksandrova K; Nöthlings U; Lukanova A; Lagiou P; Boffetta P; Trichopoulos D; Katzke VA; Overvad K; Tjønneland A; Hansen L; Boutron-Ruault MC; Fagherazzi G; Bastide N; Panico S; Grioni S; Vineis P; Palli D; Tumino R; Bueno-de-Mesquita HB; Peeters PH; Skeie G; Engeset D; Parr CL; Jakszyn P; Sánchez MJ; Barricarte A; Amiano P; Chirlaque M; Quirós JR; Sund M; Werner M; Sonestedt E; Ericson U; Key TJ; Khaw KT; Ferrari P; Romieu I; Riboli E; Jenab M
    Ann Oncol; 2013 Aug; 24(8):2166-73. PubMed ID: 23670094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
    Lukanova A; Becker S; Hüsing A; Schock H; Fedirko V; Trepo E; Trichopoulou A; Bamia C; Lagiou P; Benetou V; Trichopoulos D; Nöthlings U; Tjønneland A; Overvad K; Dossus L; Teucher B; Boeing H; Aleksandrova K; Palli D; Pala V; Panico S; Tumino R; Ricceri F; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Quiros JR; Duell EJ; Molina-Montes E; Chirlaque MD; Gurrea AB; Dorronsoro M; Lindkvist B; Johansen D; Werner M; Sund M; Khaw KT; Wareham N; Key TJ; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Jenab M; Kaaks R
    Int J Cancer; 2014 Jan; 134(1):164-73. PubMed ID: 23801371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
    Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
    J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.
    Xia H; Chen J; Sekar K; Shi M; Xie T; Hui KM
    Metabolomics; 2019 Nov; 15(12):156. PubMed ID: 31773292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort.
    Duarte-Salles T; Fedirko V; Stepien M; Aleksandrova K; Bamia C; Lagiou P; Laursen AS; Hansen L; Overvad K; Tjønneland A; Boutron-Ruault MC; Fagherazzi G; His M; Boeing H; Katzke V; Kühn T; Trichopoulou A; Valanou E; Kritikou M; Masala G; Panico S; Sieri S; Ricceri F; Tumino R; Bueno-de-Mesquita HB; Peeters PH; Hjartåker A; Skeie G; Weiderpass E; Ardanaz E; Bonet C; Chirlaque MD; Dorronsoro M; Quirós JR; Johansson I; Ohlsson B; Sjöberg K; Wennberg M; Khaw KT; Travis RC; Wareham N; Ferrari P; Freisling H; Romieu I; Cross AJ; Gunter M; Lu Y; Jenab M
    Int J Cancer; 2015 Dec; 137(11):2715-28. PubMed ID: 26081477
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.